Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001477449-24-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | TDOC | Raman-Tangella Vidya | Chief MEDICAL Off | M - OptEx | — | +12.5K | 27.2K | +85% | — |
| D | 2024-03-05 | 2024-03-04 | TDOC | Raman-Tangella Vidya | Chief MEDICAL Off | S - Sale+OE | $14.52 | -4,599 | 22.6K | -17% | -$66.8K |
| D | 2024-03-05 | 2024-03-01 | TDOC | Raman-Tangella Vidya | Chief MEDICAL Off | A - Grant | $0.00 | +9,509 | 9,509 | New | $0 |
| DM | 2024-03-05 | 2024-03-01 | TDOC | Raman-Tangella Vidya | Chief MEDICAL Off | M - OptEx | $0.00 | -12.5K | 18.6K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | M | A | 3,169 | — | 17,906 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-03-01 | M | A | 9,300 | — | 27,206 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-03-04 | S | D | 4,599 | $14.52 | 22,607 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 4 | Derivative | Performance Stock Units | 2024-03-01 | A | A | 9,509 | $0.00 | 9,509 | D | — · — to — | 9,509 Common Stock | (F5) Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. (F4) Each performance stock unit represents a contingent right to receive one share of TDOC common stock. (F6) The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 5 | Derivative | Performance Stock Units | 2024-03-01 | M | D | 3,169 | $0.00 | 6,340 | D | — · — to — | 3,169 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2024-03-01 | M | D | 9,300 | $0.00 | 18,602 | D | — · — to — | 9,300 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F8) On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |